Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $22.0 in the last session, up 0.41% from day before closing price of $21.91. In other words, the price has increased by $0.41 from its previous closing price. On the day, 0.61 million shares were traded. MD stock price reached its highest trading level at $22.19 during the session, while it also had its lowest trading level at $21.725.
Ratios:
We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.83 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.68.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 15 ’25 when ORDAN MARK S sold 23,000 shares for $22.41 per share. The transaction valued at 515,430 led to the insider holds 302,805 shares of the business.
ORDAN MARK S bought 23,000 shares of MD for $517,500 on Dec 15 ’25. On Nov 17 ’25, another insider, Rucker Michael A., who serves as the Director of the company, sold 10,478 shares for $23.00 each. As a result, the insider received 240,994 and left with 59,101 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1915852288 and an Enterprise Value of 2031150720. As of this moment, Pediatrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.61, and their Forward P/E ratio for the next fiscal year is 10.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 2.12. Its current Enterprise Value per Revenue stands at 1.057 whereas that against EBITDA is 7.885.
Stock Price History:
The Beta on a monthly basis for MD is 0.73, which has changed by 0.5981035 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $24.99, while it has fallen to a 52-week low of $11.84. The 50-Day Moving Average of the stock is 5.23%, while the 200-Day Moving Average is calculated to be 36.70%.
Shares Statistics:
According to the various share statistics, MD traded on average about 975.12K shares per day over the past 3-months and 1146780 shares per day over the past 10 days. A total of 85.83M shares are outstanding, with a floating share count of 84.39M. Insiders hold about 1.73% of the company’s shares, while institutions hold 95.49% stake in the company. Shares short for MD as of 1764288000 were 3161380 with a Short Ratio of 3.24, compared to 1761868800 on 3018804. Therefore, it implies a Short% of Shares Outstanding of 3161380 and a Short% of Float of 5.17.
Earnings Estimates
The company has 7.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.38, with high estimates of $0.41 and low estimates of $0.36.
Analysts are recommending an EPS of between $2.16 and $2.05 for the fiscal current year, implying an average EPS of $2.08. EPS for the following year is $2.19, with 7.0 analysts recommending between $2.39 and $2.11.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $486.23M. It ranges from a high estimate of $521.66M to a low estimate of $465.47M. As of. The current estimate, Pediatrix Medical Group Inc’s year-ago sales were $502.36MFor the next quarter, 7 analysts are estimating revenue of $473.79M. There is a high estimate of $479.8M for the next quarter, whereas the lowest estimate is $467.53M.
A total of 7 analysts have provided revenue estimates for MD’s current fiscal year. The highest revenue estimate was $1.94B, while the lowest revenue estimate was $1.89B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $2.01BBased on 7 analysts’ estimates, the company’s revenue will be $1.96B in the next fiscal year. The high estimate is $2.02B and the low estimate is $1.88B.
